QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when eLetters are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Mullins, C. D.
* Articles by Stuart, B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Mullins, C. D.
* Articles by Stuart, B.
Related Collections
* Pharmaceuticals
* Research And Technology

Health Tracking

TRENDS

The Impact Of Pipeline Drugs On Drug Spending Growth

C. Daniel Mullins, Junling Wang, Francis B. Palumbo and Bruce Stuart


The first 100 words of the full text of this article appear below.

Among all components of escalating health care expenditures, spending on prescription drugs is among those growing the fastest. The drug spending growth rate in 1995–1999 was more than twice that of overall health care spending. During that five-year period the annual growth in drug spending increased 10–17 percent, while annual national health expenditures increased 4–6 percent.1 Most of the prevailing literature has focused on price increases as a major component of drug spending increases. Clearly, as prices increase each year, drug spending surges upward correspondingly. However, two other components that greatly affect drug spending are product shift and utilization. Product . . . [Full Text of this Article]

   Components Of Drug Spending Increases
 
   Historical Contributions Of Price, Product, And Utilization
 
   Implications For Future Spending Trends
 
   Discussion And Policy Implications
 


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Med Care Res RevHome page
J. Wang, J. M. Noel, I. H. Zuckerman, N. A. Miller, F. T. Shaya, and C. D. Mullins
Disparities in Access to Essential New Prescription Drugs between Non-Hispanic Whites, Non-Hispanic Blacks, and Hispanic Whites.
Med Care Res Rev, December 1, 2006; 63(6): 742 - 763.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
A. D. Federman
Don't Ask, Don't Tell: The Status of Doctor-Patient Communication About Health Care Costs
Arch Intern Med, September 13, 2004; 164(16): 1723 - 1724.
[Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2001 Project HOPE–The People-to-People Organization
Terms and Policies